“Soda” by Jannes Pockele is licensed under CC BY 2.0

Breast Cancer: Sugar-Sweetened Soda Consumption May Impact Mortality Risk

MedicalResearch.com Interview with:

Nadia Koyratty PhD student Department of Epidemiology and Environmental Health University at Buffalo State University of New York

Nadia Koyratty

Nadia Koyratty PhD student
Department of Epidemiology and Environmental Health
University at Buffalo
State University of New York

MedicalResearch.com: What is the background for this study?

Response: The literature suggests that sugars contribute to the incidence of breast cancer, but few exists on the prognosis after a breast cancer diagnosis.

MedicalResearch.com: What are the main findings?

Response: Compared to breast cancer patients who never or rarely drank non-diet soda, those who reported drinking non-diet soda five times or more per week had a 62% higher likelihood of dying from any causes, and were 85% more likely to die from breast cancer specifically.

MedicalResearch.com: What should readers take away from your report?

Response: It is important to adhere to the Dietary Guidelines for Americans and the American Cancer Society which both recommend limiting the consumption of sugar sweetened beverages even among breast cancer patients.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: While we need more studies to confirm our findings, this study provides evidence that diet may impact longevity of women after breast cancer. Further research looking at potential biological mechanisms of action that contributes to the association we observed are also needed.

MedicalResearch.com: Is there anything else you would like to add?

Response: The research was supported in part by grants from the Army Medical Research and Material Command, National Cancer Institute and the National Institute on Alcohol Abuse and Alcoholism.


Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study
Nadia Koyratty, Susan E. McCann, Amy E. Millen, Jing Nie, Maurizio Trevisan and Jo L. Freudenheim
Cancer Epidemiol Biomarkers Prev March 2 2021 DOI: 10.1158/1055-9965.EPI-20-1242 



The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.


Last Updated on March 14, 2021 by Marie Benz MD FAAD